Medical Marijuana and Reduction in Opioid Use
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The IrritableBowelSyndrome.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Rudd RA, Set P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445-1452.
- Hill KP, Saxon AJ. The Role of Cannabis Legalization in the Opioid Crisis. JAMA Intern Med. Published online April 02, 2018. doi:10.1001/jamainternmed.2018.0254.
- Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population [published online April 2, 2018]. JAMA Intern Med. doi:10.1001/jamainternmed.2018.0266.
- Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees [published online April 2, 2018]. JAMA Intern Med. doi:10.1001/jamainternmed.2018.1007.
- Chadi N, Levy S. Easing access to marijuana is not a way to solve the opioid epidemic. Stat. April 12, 2018. Available at https://www.statnews.com/2018/04/12/marijuana-access-opioid-epidemic/. Accessed 4/30/18.
- Ahmed W, Katz S. Therapeutic Use of Cannabis in Inflammatory Bowel Disease. Gastroenterology & Hepatology. 2016;12(11):668-679.
- Medical cannabis and IBD. GI Society. Available at https://www.badgut.org/information-centre/a-z-digestive-topics/medical-marijuana-and-ibd/. Accessed 4/30/18.
- Esposito G, De Filippis D, Cirillo C, et al. Cannabidiol in inflammatory bowel diseases: a brief overview. Phytother Res. 2012. doi: 10.1002/ptr.4781. Available at https://lirias.kuleuven.be/bitstream/123456789/356043/1/ptr4781.pdf. Accessed 4/30/18.